Craig R Schneider
Overview
Explore the profile of Craig R Schneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wall M, Subasinghe N, Winters M, Lubin M, Finley M, Qin N, et al.
Bioorg Med Chem Lett
. 2018 Oct;
28(23-24):3780-3783.
PMID: 30337231
A novel series of pyrazolyltetrahydropyran N-type calcium channel blockers are described. Structural modifications of the series led to potent compounds in both a cell-based fluorescent calcium influx assay and a...
2.
Subasinghe N, Wall M, Winters M, Qin N, Lubin M, Finley M, et al.
Bioorg Med Chem Lett
. 2012 May;
22(12):4080-3.
PMID: 22608964
Selective blockers of the N-type calcium channel have proven to be effective in animal models of chronic pain. However, even though intrathecally delivered synthetic ω-conotoxin MVIIA from Conus magnus (ziconotide...
3.
Kimball E, Wallace N, Schneider C, DAndrea M, Hornby P
Front Pharmacol
. 2011 Jul;
1:132.
PMID: 21779244
Cannabinoids are known to be clinically beneficial for control of appetite disorders and nausea/vomiting, with emerging data that they can impact other GI disorders, such as inflammation. Post-inflammatory irritable bowel...
4.
Parks D, Parsons W, Colburn R, Meegalla S, Ballentine S, Illig C, et al.
J Med Chem
. 2010 Dec;
54(1):233-47.
PMID: 21128593
Transient receptor potential melastatin 8 (TRPM8) is a nonselective cation channel that is thermoresponsive to cool to cold temperatures (8-28 °C) and also may be activated by chemical agonists such...
5.
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists
Gong Y, Barbay J, Dyatkin A, Miskowski T, Kimball E, Prouty S, et al.
J Med Chem
. 2006 May;
49(11):3402-11.
PMID: 16722660
A novel series of pyridazinone-functionalized phenylalanine analogues was prepared and evaluated for inhibition of cellular adhesion mediated by alpha4beta1/VCAM-1 and alpha4beta7/MAdCAM-1 interactions. Concise syntheses were developed and applied for exploration...
6.
Kimball E, Schneider C, Wallace N, Hornby P
Am J Physiol Gastrointest Liver Physiol
. 2006 Apr;
291(2):G364-71.
PMID: 16574988
Oil of mustard (OM) is a potent neuronal activator that is known to elicit visceral hyperalgesia when given intracolonically, but the full extent to which OM is also proinflammatory in...
7.
Dyatkin A, Gong Y, Miskowski T, Kimball E, Prouty S, Carolyn Fisher M, et al.
Bioorg Med Chem
. 2005 Aug;
13(24):6693-702.
PMID: 16112583
A series of N-carboxy, N-alkyl, and N-carboxamido azabicyclo[2.2.2]octane carboxamides were prepared and assayed for inhibition of alpha4beta1-VCAM-1 and alpha4beta7-MAdCAM-1 interactions. Potency and alpha4beta1/alpha4beta7 selectivity were sensitive to the substituent R1-R3...
8.
Breslin H, Miskowski T, Rafferty B, Coutinho S, Palmer J, Wallace N, et al.
J Med Chem
. 2004 Oct;
47(21):5009-20.
PMID: 15456245
A small series of novel, imidazoles 4 have been prepared that exhibit very good binding affinities for the delta and mu opioid receptors (ORs), as well as demonstrate potent agonist...